This inventor holds 1 USPTO granted patent. Top assignee: Oxoid Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Gemma Howse: Innovator in Selective Cell Inhibition
Introduction
Gemma Howse is a notable inventor based in Reading, GB. She has made significant contributions to the field of biotechnology, particularly in the development of selective agents for cell culture.
Latest Patents
Gemma holds a patent for "Triclosan derivatives and uses thereof." This invention involves a selective agent comprising a triclosan derivative that is used for the selective inhibition of non-target cells in a mixed population of target and non-target cells. The preferred triclosan derivative is a glycoside derivative, more specifically a pyranoside derivative. The patent also includes a selective medium comprising the selective agent and methods for culturing cells using this agent.
Career Highlights
Gemma is currently employed at Oxoid Limited, where she continues to innovate in her field. Her work focuses on enhancing the efficiency and effectiveness of cell culture techniques.
Collaborations
Gemma collaborates with Richard A Bovill, contributing to advancements in their shared field of expertise.
Conclusion
Gemma Howse's work in developing triclosan derivatives showcases her commitment to innovation in biotechnology. Her contributions are paving the way for more effective cell culture methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile